Standard Operating Procedure for Precipitation and Clarification Steps in Biosimilar Manufacturing

Department	Biosimilars
SOP No.	SOP/BS/188/2025
Supersedes	SOP/BS/188/2022
Page No.	Page 1 of 9
Issue Date	04/05/2025
Effective Date	06/05/2025
Review Date	04/05/2026

1. Purpose

To describe a GMP-compliant procedure for executing precipitation and clarification steps in biosimilar manufacturing for the removal of impurities or concentration of the target protein prior to downstream purification.

2. Scope

This SOP applies to all biosimilar bulk drug substances requiring precipitation using salt, solvent, or pH shift followed by clarification via centrifugation or filtration under controlled conditions.

3. Responsibilities

• Production: Perform precipitation and clarification steps, monitor critical parameters, and document observations.
• Process Development: Provide optimized precipitation conditions and buffer compositions.
• QA: Review process compliance, in-process data, and ensure adherence to validation protocols.

4. Accountability

The Manufacturing Manager is accountable for the execution of precipitation and clarification steps as per the batch manufacturing record and validated procedures.

5. Procedure

5.1 Preparation for Precipitation

1. Ensure the product solution to be precipitated is clarified and within defined parameters (e.g., pH, conductivity).
2. Prepare precipitation agent: commonly used agents include:
   • Ammonium sulfate (up to 80% saturation)
   • Polyethylene glycol (PEG 6000–8000)
   • Solvent (ethanol, isopropanol)
   • pH shift using acid/base
3. Calibrate pH meter and ensure temperature is stable (2–8°C or 20–25°C as specified).

5.2 Precipitation Step

1. Under slow stirring (100–300 rpm), add precipitation agent gradually over 30–60 minutes.
2. Maintain constant temperature and pH during addition.
3. Incubate the solution for 1–2 hours post-addition or as per process parameters.
4. Monitor turbidity, pH, and conductivity periodically during precipitation.

5.3 Clarification

1. Transfer precipitated slurry to centrifuge bowl or clarification vessel.
2. Centrifuge at appropriate settings (e.g., 8,000–12,000 × g for 30–45 minutes).
3. Alternatively, use depth filters or 0.45 µm filtration system if scalable.
4. Collect supernatant (discard or retain based on target molecule) and pellet (retain or discard).

5.4 Post-Processing

1. Resuspend pellet (if product-rich) in appropriate buffer if required for further purification.
2. Label clarified fractions with sample ID and transfer to next processing stage.

5.5 In-Process Testing

1. Collect samples before and after precipitation for:
   • Protein concentration
   • Solubility/turbidity
   • pH and conductivity

6. Abbreviations

• PEG: Polyethylene Glycol
• rpm: Revolutions Per Minute
• g: Relative Centrifugal Force
• GMP: Good Manufacturing Practice

7. Documents

1. Precipitation and Clarification Log – Annexure-1
2. Precipitant Preparation Record – Annexure-2
3. In-Process Sample Analysis Sheet – Annexure-3

8. References

• ICH Q8 – Pharmaceutical Development
• WHO TRS 1004 – GMP for Biotherapeutics
• FDA Guidance – Biotech Product Process Validation

9. SOP Version

Version: 2.0

10. Approval Section

	Prepared By	Checked By	Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Precipitation and Clarification Log

Date	Batch No.	Agent Used	pH	Temp (°C)	Operator
04/05/2025	BS-PREC-023	Ammonium Sulfate	5.5	4	Ajay Verma

Annexure-2: Precipitant Preparation Record

Solution	Component	Concentration	Volume Prepared	Prepared By
Sulfate Buffer	Ammonium Sulfate	80% Sat.	10 L	Sunita Reddy

Annexure-3: In-Process Sample Analysis Sheet

Sample ID	Stage	Protein (mg/mL)	pH	Turbidity	Analyst
PRE-01	Before Precipitation	3.2	6.0	Low	Dr. Neha Rao
POST-01	After Clarification	3.5	5.5	Clear	Dr. Neha Rao

Revision History:

Revision Date	Revision No.	Details	Reason	Approved By
04/05/2025	2.0	Updated filtration alternative, added real-time monitoring criteria	GMP Compliance